FDA Inks Class II Designation For Embryo Viability Tests
This article was originally published in The Gray Sheet
Executive Summary
The agency set a class II with special controls designation for assisted reproduction embryo image assessment systems in a Feb. 26 final order, following the de novo decision for Auxogyn’s Eeva system last summer.
You may also be interested in...
Testing For Toxicity In Fertility Treatment Technologies
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Daiichi's Novel EZH Candidate Moves Ahead With New Consortium Trial
Japanese major links with new partners in European consortium to progress first-in-class molecule for multiple hematological malignancies.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: